Gastric Cancer Market Research Report 2024-2030 by Immunotherapy, Chemotherapy, Radiation Therapy, Surgery, Target Therapies, PD-1/PD-L1 Inhibitors, HER2 Antagonists VEGFR2 Antagonists Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Gastric Cancer Market (2024 Edition): Analysis By Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal...

Global Gastric Cancer Market Expected to Accumulate a Revenue of $10,737.00 Million by 2031, Growing at a Healthy CAGR of 17.9% [350-Pages] | Initiative by Research Dive New York, USA, June 01, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global gastric cancer market is anticipated to rise at a stable CAGR of 17.9%, thereby...

Gastric Cancer Market Is Expected to Reach $10.7 Billion by 2031: Allied Market Research Portland, OR, April 14, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global gastric cancer market generated $2.1 billion in 2021, and is estimated to...

Global Gastric Cancer Forecast and Market Analysis Report 2020-2027 - Trastuzumab Biosimilars are Now Available, Leading to a Sharp Decline in the Market Share of Herceptin Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Gastric Cancer Forecast and Market Analysis" drug pipelines has been added to ResearchAndMarkets.com's offering. The report estimates that in 2018,...

Stomach Cancer/Gastric Cancer Treatment Market to Reach USD 8.20 Billion by 2026; Rapid Adoption of PD-1 Inhibitors for Treating Gastric Cancers to Boost the Market: Fortune Business Insights™ Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Stomach Cancer Treatment Market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of...